/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Recurrent atherosclerotic cardiovascular disease events preventable with guideline recommended lipid-lowering treatment following myocardial infarction
Event: ESC Congress 2022
Topic: Drug therapy
Session: Lipids - Drug therapy 1
Assessment of cardiovascular disease risk using different thresholds to define high risk on the pooled cohort equations
Event: ESC Congress 2018
Topic: Cardiovascular Epidemiology
Session: Atrial fibrillation, stroke and cardiovascular risk
Residual risk following myocardial infarction despite intensive medical management
Event: ESC Congress 2018
Topic: Cardiovascular Pharmacotherapy, Other
Session: Antiplatelet and anticoagulant drugs
Panel discussion and Q&A - Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol.
Event: ESC Congress 2017
Topic: Risk scores
Session: Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol
The burden of hypertension and high cholesterol – Impact of non-compliance and failure to reach goals.
Event: ESC Congress 2017
Topic: Risk scores
Session: Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol
Adherence to intensive medical management in the year following hospitalization for myocardial infarction
Event: ESC Congress 2017
Topic: Epidemiology, lipids
Session: Prevention - Epidemiology
Statin use among HIV-infected adults by cardiovascular disease risk status
Event: ESC Congress 2017
Topic: Lipids (Epidemiology and Prevention)
Session: Lipid-lowering therapy: old faces and new issues
Statin use and dose by low-density lipoprotein cholesterol level in U.S. commercially insured patients with type 2 diabetes
Event: ESC Congress 2016
Topic: Epidemiology, lipids
Session: Are we ever going to get to lipid goals?
Increased recurrent coronary heart disease and mortality risk among intensive medically managed patients following myocardial infarction
Event: ESC Congress 2016
Topic: Epidemiology, lipids
Session: The wide world of cardiovascular research and practice
Trends in high-intensity statin therapy after myocardial infarction, 2011-2014
Event: ESC Congress 2016
Topic: Epidemiology, lipids
Session: Cardiovascular risk in populations
ESC 365 is supported by
